Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Tziomalos, K., Athyros V. G., & Mikhailidis D. P. (2009).  Colesevelam improves glycemic control and lipid management in inadequately controlled type 2 diabetes mellitus.. Nat Clin Pract Endocrinol Metab. 5(1), 16-7.
Tziomalos, K., Athyros V. G., Mikhailidis D. P., & Karagiannis A. (2013).  Hydrochlorothiazide vs. chlorthalidone as the optimal diuretic for the management of hypertension.. Curr Pharm Des. 19(21), 3766-72.
Tziomalos, K., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2007).  Endothelial function, arterial stiffness and lipid lowering drugs.. Expert Opin Ther Targets. 11(9), 1143-60.
Tziomalos, K. (2009).  Combination treatment in HBeAg-negative chronic hepatitis B.. World J Hepatol. 1(1), 43-7.
Tziomalos, K., Katsikis I., Papadakis E., Kandaraki E. A., Macut D., & Panidis D. (2013).  Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.. Hum Reprod. 28(3), 785-93.
Tziomalos, K., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2010).  Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management.. Nutr Metab Cardiovasc Dis. 20(2), 140-6.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Kostaki S., Papadopoulou M., et al. (2016).  Treatment with Clopidogrel Prior to Acute Non-Cardioembolic Ischemic Stroke Attenuates Stroke Severity.. Cerebrovasc Dis. 41(5-6), 226-32.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Papadopoulou M., Kostaki S., et al. (2015).  Elevated diastolic but not systolic blood pressure increases mortality risk in hypertensive but not normotensive patients with acute ischemic stroke.. Am J Hypertens. 28(6), 765-71.
Tziomalos, K., Bouziana S. D., Spanou M., Kostaki S., Papadopoulou M., Giampatzis V., et al. (2015).  Prior treatment with dipeptidyl peptidase 4 inhibitors is associated with better functional outcome and lower in-hospital mortality in patients with type 2 diabetes mellitus admitted with acute ischaemic stroke.. Diab Vasc Dis Res. 12(6), 463-6.
Tziomalos, K., Athyros V. G., & Karagiannis A. (2015).  Cardiovascular Risk in Middle East Populations: A Call to Action.. Angiology. 66(9), 801-2.
Tziomalos, K., Karagiannis A., & Athyros V. G. (2014).  Effects of lipid-lowering agents on inflammation, haemostasis and blood pressure.. Curr Pharm Des. 20(40), 6306-13.
Tziomalos, K., Vakalopoulou S., Perifanis V., & Garipidou V. (2009).  Treatment of congenital fibrinogen deficiency: overview and recent findings.. Vasc Health Risk Manag. 5, 843-8.
Tziomalos, K. (2017).  Barriers to insulin treatment in patients with type 2 diabetes mellitus.. Expert Opin Pharmacother. 18(3), 233-234.
Tziomalos, K., Florentin M., Krikis N., Perifanis V., Karagiannis A., & Harsoulis F. (2007).  Persistent effect of zoledronic acid in Paget's disease.. Clin Exp Rheumatol. 25(3), 464-6.
Tziomalos, K., Ganotakis E. S., Gazi I. F., Nair D. R., & Mikhailidis D. P. (2009).  Kidney function and estimated vascular risk in patients with primary dyslipidemia.. Open Cardiovasc Med J. 3, 57-68.
Tziomalos, K., Spanou M., Bouziana S. D., Papadopoulou M., Giampatzis V., Kostaki S., et al. (2014).  Type 2 diabetes is associated with a worse functional outcome of ischemic stroke.. World J Diabetes. 5(6), 939-44.
Tziomalos, K., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2011).  Dyslipidemia induced by drugs used for the prevention and treatment of vascular diseases.. Open Cardiovasc Med J. 5, 85-9.
Tziomalos, K., Krassas G. E., & Tzotzas T. (2009).  The use of sibutramine in the management of obesity and related disorders: an update.. Vasc Health Risk Manag. 5(1), 441-52.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Kostaki S., Papadopoulou M., et al. (2017).  Effect of antihypertensive treatment on the long-term outcome of patients discharged after acute ischemic stroke.. Clin Exp Hypertens. 39(3), 246-250.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Kostaki S., Papadopoulou M., et al. (2015).  Comparative effects of more versus less aggressive treatment with statins on the long-term outcome of patients with acute ischemic stroke.. Atherosclerosis. 243(1), 65-70.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Papadopoulou M., Kostaki S., et al. (2015).  Response to "Brachial Systolic Blood Pressure Fails to Predict Short-Term Outcome in Patients With Acute Ischemic Stroke: What About Central Systolic Pressure?".. Am J Hypertens. 28(9), 1181.
Tziomalos, K., Dimitroula H. V., Katsiki N., Savopoulos C., & Hatzitolios A. I. (2010).  Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients.. Mediators Inflamm. 2010, 364957.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Kostaki S., Papadopoulou M., et al. (2016).  Acenocoumarol vs. low-dose dabigatran in real-world patients discharged after ischemic stroke.. Blood Coagul Fibrinolysis. 27(2), 185-9.
Tziomalos, K. (2017).  The Role of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in the Management of Dyslipidemia.. Curr Pharm Des. 23(10), 1495-1499.
Tziomalos, K., Athyros V. G., Paschos P., & Karagiannis A. (2015).  Nonalcoholic fatty liver disease and statins.. Metabolism. 64(10), 1215-23.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές